Target Discovery and Validation Reviews and Protocols

Molecular Profiling of Breast Cancer 113
46. Kannan, K., Kaminski, N., Rechavi, G., et al. (2001) DNA microarray analysis of
genes involved in p53 mediated apoptosis: activation of Apaf-1. Oncogene 20,
3449–3455.
47. Yoon, H., Liyanarachchi, S., Wright, F. A., Davuluri, R., Lockman, J. C., de la,
C. A., and Pellegata, N. S. (2002) Gene expression profiling of isogenic cells
with different TP53 gene dosage reveals numerous genes that are affected by
TP53 dosage and identifies CSPG2 as a direct target of p53. Proc. Natl. Acad. Sci.
USA 99, 15,632–15,637.
48. Schaner, M. E., Ross, D. T., Ciaravino, G., et al.. (2003) Gene expression patterns
in ovarian carcinomas. Mol. Biol. Cell 14, 4376–4386.
49. Alizadeh, A. A., Eisen, M. B., Davis, R. E., et al. (2000) Distinct types of diffuse
large B-cell lymphoma identified by gene expression profiling [see comments].
Nature 403, 503–511.
50. Chen, X., Cheung, S. T., So, S., et al. (2002) Gene expression patterns in human
liver cancers. Mol. Biol. Cell 13, 1929–1939.
51. Lapointe, J., Li, C., Higgins, J. P., Van de, R. M., et al. (2004) Gene expression
profiling identifies clinically relevant subtypes of prostate cancer. Proc. Natl.
Acad. Sci. USA 101, 811–816.
52. Ford, D., Easton, D. F., Stratton, M., et al. (1998) Genetic heterogeneity and penetrance
analysis of the BRCA1 and BRCA2 genes in breast cancer families. The
Breast Cancer Linkage Consortium. Am. J. Hum. Genet., 62, 676–689.
53. Hedenfalk, I., Duggan, D., Chen, Y., et al. (2001) Gene-expression profiles in
hereditary breast cancer. N. Engl. J. Med. 344, 539–548.
54. Armes, J. E., Trute, L., White, D., et al. (1999) Distinct molecular pathogeneses
of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based
study. Cancer Res. 59, 2011–2017.
55. Lakhani, S. R., Reis-Filho, J. S., Fulford, L., et al. (2005) Prediction of BRCA1
status in patients with breast cancer using estrogen receptor and basal phenotype.
Clin. Cancer Res. 11, 5175–5180.
56. Fan, S., Wang, J., Yuan, R., Ma, Y., et al. (1999) BRCA1 inhibition of estrogen
receptor signaling in transfected cells. Science, 284, 1354–1356.
57. Razandi, M., Pedram, A., Rosen, E. M., and Levin, E. R. (2004) BRCA1 inhibits
membrane estrogen and growth factor receptor signaling to cell proliferation in
breast cancer. Mol. Cell Biol. 24, 5900–5913.
58. Finlin, B. S., Gau, C. L., Murphy, G. A., et al. (2001) RERG is a novel ras-related,
estrogen-regulated and growth-inhibitory gene in breast cancer. J. Biol. Chem.
276, 42,259–42,267.
59. Balint, E. E. and Vousden, K. H. (2001) Activation and activities of the p53
tumour suppressor protein. Br. J. Cancer 85, 1813–1823.
60. Guimaraes, D. P. and Hainaut, P. (2002) TP53: a key gene in human cancer.
Biochimie, 84, 83–93.
61. Vogelstein, B., Lane, D., and Levine, A. J. (2000) Surfing the p53 network. Nature
408, 307–310.